Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Antibody Levels Following Second Dose of ChAdOx1 nCov-19 or BNT162b2 Vaccine in Residents of Long-term Care Facilities in England (VIVALDI)

General population studies have shown strong humoral response following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination with subsequent waning of anti-spike antibody levels. Vaccine-induced immune responses are often attenuated in frail and older populations, but published d...

Descripción completa

Detalles Bibliográficos
Autores principales: Stirrup, Oliver, Krutikov, Maria, Tut, Gokhan, Palmer, Tom, Bone, David, Bruton, Rachel, Fuller, Chris, Azmi, Borscha, Lancaster, Tara, Sylla, Panagiota, Kaur, Nayandeep, Spalkova, Eliska, Bentley, Christopher, Amin, Umayr, Jadir, Azar, Hulme, Samuel, Giddings, Rebecca, Nacer-Laidi, Hadjer, Baynton, Verity, Irwin-Singer, Aidan, Hayward, Andrew, Moss, Paul, Copas, Andrew, Shallcross, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047242/
https://www.ncbi.nlm.nih.gov/pubmed/35429382
http://dx.doi.org/10.1093/infdis/jiac146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047242/
https://www.ncbi.nlm.nih.gov/pubmed/35429382
http://dx.doi.org/10.1093/infdis/jiac146

Ejemplares similares